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Abstract  
       For nearly 60 years the ATP activation and the CTP inhibition of Escherichia coli 
aspartate transcarbamoylase (ATCase) has been the textbook example of allosteric 
regulation. We present kinetic data and 5 X-ray structures determined in the absence and 
presence of a Mg2+ concentration within the physiological range. In the presence of 2 
mM divalent cations (Mg2+, Ca2+, Zn2+) CTP does not significantly inhibit the enzyme 
while the allosteric activation by ATP is enhanced. The data suggest that the actual 
allosteric inhibitor in vivo of ATCase is the combination of CTP, UTP and a M2+ cation 
and the actual allosteric activator is ATP and M2+ or ATP, GTP and M2+. The structural 
data reveals that two NTPs can bind to each allosteric site with a Mg2+ ion acting as a 
bridge between the triphosphates. Thus the regulation of ATCase is far more complex 
than previously believed and calls many previous studies into question. The X-ray 
structures reveal the catalytic chains undergo essentially no alternations, however, several 
regions of the regulatory chains undergo significant structural changes.  Most significant 
is that the N-terminal regions of the regulatory chains exist in different conformations in 
the allosterically activated and inhibited forms of the enzyme. Here, a new model of 
allosteric regulation is proposed. 
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 1
Introduction 
Nucleotides and Divalent Metal 
       Nucleotides play a variety of important roles in all cells and are essential to life. A 
nucleotide is composed of a phosphate, a ribose sugar and either a purine or pyrimidine 
base (Figure 1). ATP and GTP are purine triphosphate nucleotides while CTP, UTP, TTP 
are pyrimidine triphosphate nucleotides. It is well known that these nucleotides are the 
components of genetic information, present as the activated precursors of DNA and 
RNA. They are also involved in a great number of intracellular and intercellular 
functions. For example, GTP, guanosine triphosphate, serves as substrate in the signal 
transduction pathways. Signal transduction by G-protein coupled receptors (GPCRs), 
transmembrane proteins, involves a conformational change upon binding of GTP to the 
proteins.1 The hydrolysis of ATP, adenosine triphosphate, provides a lot of energy thus it 
is the universal currency of energy in biological systems, and it is the most abundant 
among the nucleotides.2 Similar to ATP, CTP and UTP are also high-energy molecules. 
One of the roles of CTP and UTP is feedback inhibition of one of the enzyme required to 
catalyze the committed step in the pyrimidine biosynthesis pathway, the reaction 
catalyzed by aspartate transcarbamoylase, therefore maintaining a balance in the 
pyrimidine pool.3 
       Divalent metals, such as Mg2+, exist at high concentration in cells, are important for 
plants and animals and also are involved in numerous enzymatic reactions. For example, 
chlorophyll, responsible for the green color of plants, has a Mg2+ coordinated to the 
clorin. Mg2+ is also required in the process of DNA replication, serving as essential 
cofactor in the DNA polymerase reaction.4 
 Figure 1. Chemical Structures of ATP, GTP, CTP and UTP
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       In case of aspartate transcarbamoylase, both nucleotides and divalent metals together 
regulate its activity. Numerous studies have been performed to illustrate how the 
functionality of the enzyme is regulated, including structural crystallography analysis, 
small angle X-ray scattering, site-directed mutagenesis and kinetic studies. Although the 
important role of the nucleotides effectors is well accepted, the mode by which different 
nucleotides bring about different modes of regulation is still unclear. In this study a 
variety of methods are used to better understand the role of metal ions in the regulation of 
aspartate transcarbamoylase. 
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Aspartate Transcarbamoylase 
Homotropic Cooperativity 
       Aspartate transcarbamoylase (ATCase) catalyzes the first reaction of the pyrimidine 
biosynthetic pathway, which is the carbamylation of the amino group of aspartate by 
carbamoyl phosphate (Figure 2).5 The E. coli ATCase holoenzyme (310 kDa) is 
composed of two catalytic trimers (34 kDa) and three regulatory dimers (17 kDa), 
arranged along a 3-fold axis of symmetry (Figure 3). Both the catalytic and regulatory 
chains have two structural domains.6 Each catalytic chain consists of the aspartate (Asp) 
domain and carbamoyl phosphate (CP) domain, which bind to the substrates aspartate 
and carbamoyl phosphate, respectively. Each regulatory chain consists of two domains, 
the allosteric (Al) domain and zinc (Zn) domain, which contains the allosteric binding 
site and structural Zn atom, respectively. ATCase exists in an equilibrium7 between two 
states that are defined by changes in the tertiary and quaternary structures: a low activity, 
low affinity for substrates taut (T-state) structure, and a high activity, high affinity for 
substrates relaxed (R-state) form. The main rigid body movements of the subunits 
describing the quaternary structure transition include an 11 Å vertical expansion along 
the 3-fold axis, and a 12 degree rotation of the catalytic trimers relative to each other 
around this axis, along with a 15 degree rotation of each of the three regulatory dimers 
around the 2-fold axes.8 In the absence of substrates, the [T]/[R] ratio is about 250 thus 
the equilibrium favors the T state.9 Binding of the substrates, or substrate analogs (e.g. N-
phosphonoacetyl-L-aspartate; PALA) (Figure 2) shifts the equilibrium from T to R in a 
concerted fashion. The transition between the T state and R state of ATCase can be 
explained by the Monod, Wyman, Changeux (MWC) model.10 In this model, the binding  
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Figure 2. Carbamoylation Reaction catalyzed by ATCase 
  
                 
Figure 3A. Structure of E. coli
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 of one ligand to the enzyme induces conformational changes that are propagate to all the 
other subunits. Therefore all subunits of the enzyme exit in the same conformation and 
the transition is concerted. The MWC model explains the transition of ATCase from T 
state to R state during catalysis. The reaction catalyzed by ATCase follows an ordered-
binding mechanism.11 First, the substrate CP binds to the active site, which induces local 
conformational changes around the active site allowing the second substrate Asp to bind 
while the enzyme still remains in T state. Next, Asp binds to the active site, induces the 
quaternary conformational changes converting the entire enzyme to R state. Thus, the 
Asp saturation curve for ATCase exhibits homotropic cooperativity.12 In addition, small-
angle X-ray scattering has shown that the binding of PALA to one of the six active sites 
was sufficient to induce a concerted transition of the entire molecule to the R state13 
providing supports that ATCase follows the MWC model.  
 
Heterotropic Regulation 
      ATCase is also heterotropically regulated by allosteric effectors14, and has been used 
as a model for allosteric regulation. Allosteric regulation occurs when a small natural 
compound binds to the enzyme at a site other than the substrate-binding site. These 
compounds are known as allosteric effectors, and they regulate the activity of enzyme. In 
E. coli ATCase, the allosteric site in the regulatory chain is located approximately 60Å 
from the active site in the catalytic chain. Aside from the homotropic regulation by its 
substrate aspartate; pyrimidine and purine nucleotides heterotropically regulate ATCase 
where ATP enhances the activity of ATCase while CTP and UTP synergistically inhibit 
it. Binding of CTP to the allosteric site greatly increases the [T]/[R] to 1250, thus shifting 
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the equilibrium towards the T state, while the binding of ATP to the same allosteric site 
significantly decreases the [T]/[R] to 70, thus shifting the equilibrium toward the R state.9 
This shift in equilibrium explains the decreased activity of the enzyme in the presence of 
CTP and the increased activity of the enzyme in the presence of ATP at a fixed 
concentration of aspartate. The regulatory nucleotides cannot induce the transition from 
the T to the R state, although they do alter the equilibrium between the two states.  
       Each of the allosteric effectors has been shown to have an enhanced kinetic response 
when bound with a synergistic effector. In the case of CTP, the synergistic effector UTP 
decreases the activity of ATCase in the presence of CTP more than CTP alone.3 The 
synergistic inhibition of ATCase by the combination of CTP and UTP reduces the 
enzyme activity by approximately 95%. In the case of ATP, the synergistic effector Mg2+ 
increases the activity of ATCase in the presence of ATP substantially more than ATP 
alone.15 In fact, ATP•Mg2+ has been postulated to cause a more elongated R state of 
ATCase by small-angle X-ray scattering in solution.15  
 
One Regulatory Chain Has Two Nucleotide Binding Site 
       Mendes et al.16 studied the allosteric effects of nucleotide binding to ATCase through 
the incorporation of an unnatural fluorescent amino acid close to the allosteric site of the 
enzyme. The functional mutant enzyme was generated via incorporation of the 
fluorescent amino acid, L-(7-hydroxycoumarin-4-yl)ethylglycine (HCE-Gly) into 
position 52 on the regulatory chain using procedures developed in the Schultz 
laboratory17. Analysis of fluorescence binding isotherms indicated that CTP and UTP 
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bind independently, suggesting that CTP and UTP do not compete for the same binding 
site.  
       Recent, structural studies of ATCase with UTP bound have revealed more 
information about how nucleotides bind to the allosteric sites.18 The X-ray structural 
analysis of the E. coli ATCase bound with UTP showed that each regulatory chain 
contains one allosteric site composed of the A and B subsites. Previous studies showed 
CTP and ATP compete for a same site,19 and this site has been defined as the A subsite. 
The B site, located directly adjacent to the A site, is where UTP binds. Two UTP can 
bind together filling both subsites in the presence of Mg2+. 
       Another study by our group on the synergistic inhibition of ATCase by UTP in the 
presence of CTP uncovered that the presence of a metal ion (e.g. Mg2+) was critical for 
synergistic inhibition.3 In this study, dCTP was used as a surrogate for CTP to determine 
the structure of the enzyme in the presence of both dCTP and UTP. This structure 
revealed that the allosteric site of each regulatory chain could bind two nucleotides 
simultaneously with a divalent cation coordinated between the β and ɣ phosphates of 
each nucleotide (see Figure 4). CTP or dCTP bind in essentially the same manner to the 
A subsite and UTP binds to the B subsite. This work also showed that in the absence of 
divalent cations UTP was unable to synergistically inhibit ATCase in the presence of 
CTP. Based upon these data, a new model of allostery for E. coli ATCase was proposed. 
In this model, the B site acts as an amplification site and the nucleotide in the B site will 
only amplify the kinetic response from the nucleotide bound in the A site if a metal ion is 
present. This amplified response was theorized to be an effect of a stronger shift in 
equilibrium between the T and R states when two nucleotides and a metal ion occupied 
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the allosteric site than if only one nucleotide was bound. It was speculated that this new 
model could explain the enhanced activity of the enzyme in the presence of ATP•Mg2+ as 
compared to ATP alone. Our studies show that in the presence of Mg2+, two ATP 
molecules bind together in the allosteric site of ATCase, one in each subsite, with a Mg2+ 
coordinated between their phosphate groups.  
       This thesis presents the results and analysis of 5 structures of ATCase, obtained by 
X-ray crystallography, in the R state with nucleotides bound in the presence or absence of 
Mg2+: ATCase•CTP•Mg2+•UTP, ATCase•ATP•Mg2+•ATP, ATCase•UTP•Mg2+•UTP, 
ATCase•ATP, ATCase•CTP. In addition, we use kinetics studies to investigate the role of 
divalent cations on the allosteric regulation. We chose Mg2+, Cu2+ and Zn2+ because of 
their highly abundant existence in the cells. 
 
 
 
 Figure 4. T-state X-ray crystal structure of ATCase in the presence of dCTP, UTP and 
Mg2+. The r6 regulatory subsites A and B are shown as a surface representation. dCTP is 
in the A subsite and UTP is in the B subsite. The Mg
coordinated ligand interactions are shown with magenta lines. Hydrogen
interactions to the enzyme and waters are shown as dash lines (black). Water ligands to 
Mg2+ are shown as red spheres. This figure was drawn with CHIMER
4FYX3. 
2+ is shown as a green sphere and 
A20 using PDB ID 
11
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A New Paradigm for Allosteric Regulation of Escherichia coli 
Aspartate Transcarbamoylase 
Material And Methods 
Materials 
Ampicillin, magnesium chloride hexahydrate, UTP, glycine, glucose, EDTA, agar, L-
aspartate, N-carbamoyl-L-aspartate, 2-mercaptoethanol, and uracil were obtained from 
Sigma-Aldrich (St. Louis, MO). CTP and 2-bis(2-hydroxyethyl)amino-2-
(hydroxymethyl)-1,3-propanediol (Bis-Tris) were from Santa Cruz Biotechnology, Inc. 
(Santa Cruz, CA). Tris, N-cyclohexyl-3-aminopropanesulfonic acid (CAPS), 
electrophoresis-grade acrylamide, enzyme-grade ammonium sulfate and GTP were from 
MP Biomedicals (Santa Ana, CA). Antipyrine, diacetylmonoxime, sodium molybdate 
dihydrate, tryptone and yeast extract were obtained from Fisher (Pittsburgh, PA). 
Casamino acid was from Becton, Dickinson and Company (Franklin Lakes, NJ). 
Agarose, ammonium persulfate, sodium dodecyl sulfate, coomassie brilliant blue and 
Chelex 100 resin were purchased from Bio-Rad (Hercules, CA). The carbamoyl 
phosphate dilithium salt obtained from Sigma-Aldrich was purified before use by 
precipitation from 50% (v/v) ethanol and was stored desiccated at -20° C.1 
 
Enzyme Expression and Purification 
       E. coli ATCase was overexpressed in M9 media supplemented with 5 g/L casamino 
acids using E. coli strain EK11042 [F- ara, thi, ∆(pro-lac), ∆pyrB, pyrF±, rpsL] 
transformed with plasmid pEK1523 containing the E. coli pyrBI gene. The isolation and 
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purification was as previously described.4 Enzyme concentrations were determined by 
absorbance measurements at 280 nm with an extinction coefficient of 0.59 cm2/mg.5 
Determination of ATCase Activity  
       Activity measurement with the nucleotide effectors ATP, CTP, GTP and UTP were 
performed in the absence and presence of Mg2+, Ca2+, and Zn2+ at 28° C. Pretreatment of 
nucleotides with Chelex 100 resin (Bio-Rad) were carried out to remove cation 
contamination in the commercial supply. Chelex 100 resin was added to each nucleotide 
solution (0.05 g per 1 mL). The mixture was stirred gently on ice for 1 hr. Resin was 
removed by centrifugation and the nucleotide solution with metal removed was obtained 
as supernatant. When required, MgCl2, CaCl2, or ZnCl2 were added to adjust the M
2+ 
concentration.  
       The concentration of the nucleotide triphosphates was determined 
spectrophotometrically at pH 7.0 using previously reported values of molar absorptivity.6 
The activity of the transcarbamoylase reaction was determined colorimetrically7 in a tri-
part buffer containing 20 mM Bis-Tris, 20 mM Tris, and 20 mM CAPS or a Tris buffer 
containing 50 mM Tris, at pH 7.0 or pH 8.3, respectively, in the presence of a saturating 
concentration of carbamoyl phosphate (2.0 mM). Specific activity is in units of mM N-
carbamoyl-L-aspartate•min-1•mg-1. The L-aspartate concentration was varied from 0 to 80 
mM and 0 to 100 mM at pH 7.0 and pH 8.3, respectively for the data in Figure 68 and the 
concentration of wild-type ATCase varied from 3 x 10-5 to 30 x 10-5 mg/ml. The values 
reported are the average of four determinations. Fitting of the experimental data to 
theoretical equations was accomplished by nonlinear regression. Data is shown in Table 
1. 
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Table 1. Influence of Allosteric Effectors on the Relative Activitya of 
ATCase in the Absence and Presence of Mg2+. 
 Mg2+ (mM)d 
                             -------------------------------------------------------------   
NTPb Reported Valuec 0                               1.0                          2.0 
none 1.0 1.0                            1.0                          1.0 
ATP 1.35 1.29 ± 0.07        1.33 ± 0.07             1.52 ± 0.13 
CTP 0.43 0.49 ± 0.01        0.80 ± 0.05             0.97 ± 0.05 
UTP 0.95 0.99 ± 0.01        0.97 ± 0.01             0.89 ± 0.04 
GTP 0.71 0.95 ± 0.05        0.61 ± 0.06             0.84 ± 0.04 
ATP + CTP 0.85 0.87 ± 0.02                        1.25 ± 0.03 
ATP + UTP 1.52 1.40 ± 0.06                        1.43 ± 0.06 
ATP + GTP 1.58 1.38 ± 0.04                        1.57 ± 0.05 
CTP + UTP 0.06 0.47 ± 0.10                        0.12 ± 0.04 
CTP + GTP 0.58 0.61 ± 0.08                        0.81 ± 0.15 
UTP + GTP 0.84 0.68 ± 0.01                        0.75 ± 0.02 
a Relative activity was determined by dividing the value of specific activity of ATCase in 
the presence of nucleotide(s) by that in the absence of nucleotide(s). 
b All nucleotide concentrations were 2 mM. 
c The relative activities reported by Wild et al. 9 
d All experiments were performed at 28 °C in 20 mM Bis-Tris, 20 mM Tris, and 20 mM 
CAPS buffer, pH 7.0 at saturating carbamoyl phosphate (2 mM) and 5 mM aspartate. The 
values reported are the average of four determinations. 
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Crystallization, X-ray Data Collection, and Processing 
       E. coli ATCase (10 mg/mL) was placed in 50 µL dialysis buttons (Hampton 
Research, Aliso Viejo, CA) and dialyzed against 20 mL of crystallization buffer (50 mM 
maleic acid, 1 mM PALA, and 3 mM sodium azide, pH 5.90) at 20° C.10 Crystals formed 
in about 1 week with average dimensions of 0.6 x 0.2 x 0.2 mm. Dialysis buttons were 
transferred to 1 mL of crystallization buffer with either 5 mM CTP, 5 mM ATP, 5 mM 
each of ATP and MgCl2, 5 mM each of UTP and MgCl2, or 5 mM each of CTP, UTP and 
MgCl2, and allowed to equilibrate for 12 hours. The crystals were dipped in 
crystallization buffer with 5 mM each of the matching nucleotide and MgCl2 with 20% 
(v/v) 2-methyl-2,4-pentandiol as a cryo-protectant for approximately 1 minute prior to 
flash freezing.  
       The data for the crystals soaked in CTP alone, UTP•Mg2+, and ATP•Mg2+ were 
collected on beamline X29 at the National Synchrotron Light Source at Brookhaven 
National Laboratory (Upton, NY), while the data for crystals soaked in the presence ATP 
alone and CTP•Mg2+•UTP were collected with a Rigaku MicroMax-07 HF high-intensity 
microfocus rotating Cu anode X-ray generator coupled with Osmic VariMax Optics and a 
R-Axis IV++ image plate area detector that is part of the Boston College Crystallography 
Facility. The diffraction data were integrated, scaled, and averaged using either 
HKL200011 or d*TREK (Rigaku/MSC).12  Data collection and refinement statistics are 
shown in Table 2. 
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Table 2. Data Collection and Refinement Statisticsa 
 RPALA•ATP RPALA•CTP  RPALA•UTP•Mg
2+•UTP RPALA•ATP•Mg
2+•ATP RPALA•CTP•Mg
2+•UTP 
Data collection statistics 
PDB entry 4KGV 4KGX 4KGZ 4KH0 4KH1 
Space Group P321 P321 P321 P321 P321 
Wavelength 1.542 1.075 1.075 1.075 1.542 
Cell Dimensions 
a = b, c (Å) 121.1, 155.5 121.2, 154.7 121.4, 155.1 121.1, 155.1 120.9, 154.7  
α, β, γ (°) 90, 90, 120 90, 90, 120 90, 90, 120 90, 90, 120 90, 90, 120 
Resolution (Å) 38.4 - 2.1 (2.2 - 2.1) 50 - 2.2 (2.3 - 2.2) 50 - 2.4 (2.5 - 2.4) 50 - 2.25 (2.33 - 2.25) 31.8 - 2.2 (2.3 - 2.2) 
Rsym
b 0.05 (0.38) 0.08 (0.65) 0.11 (0.68) 0.09 (0.74) 0.04 (0.37) 
Average (I/σ) 12.8 (3.3) 19.9 (3.9) 14.6 (3.7) 21.8 (3.7) 17.8 (3.8) 
Completeness (%) 100.0 (100.0) 100.0 (99.9) 100.0 (100.0) 100.0 (100.0) 99.4 (100.0) 
Redundancy 5.3 (5.3) 22.4 (18.9) 24.1 (21.2) 24.1 (22.0) 5.7 (5.6) 
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Refinement statistics 
Resolution (Å) 38.4 - 2.1 49.7 - 2.2 49.8 - 2.4 49.7 - 2.25 31.8 - 2.2 
Reflections 77,282 67,081 52,387 62,983 66,367 
Rwork/Rfree 0.168 / 0.208 0.156 / 0.192 0.165 / 0.203 0.168 / 0.208 0.163 / 0.196 
Number of atoms 
 Protein 7,098 7,082 7,074 7,202 7,132 
 Waters 688 683 339 467 458 
RMS deviations 
 Bond lengths (Å) 0.007 0.007 0.009 0.007 0.008 
 Angles (°) 1.07 1.07 1.09 1.13 1.08  
 Mean B value (Å2) 48.3 39.3 56.9 48.2 60.2 
a Values in parentheses are for the highest resolution shell. 
b Rsym = ∑|(I - <I>)|/∑(I), where I is the observed intensity. 
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Structure Solution and Data Refinement 
       Each structure was solved using phases from the RPALA structure (PDB ID: 1D09)
13 
as the initial model after removal of water and ligand molecules. Automated refinements 
using translation libration screw-motion (TLS) parameters were performed in PHENIX 
after an initial rigid body refinement.14 Manual rebuilding, addition of waters, and 
nucleotide modeling were performed using COOT.15 Waters were accepted if they were 
within hydrogen-bonding distance of main-chain or side-chain atoms. The final structures 
were validated using MolProbity14 and PROCHECK.16 Coordinates and structure factors 
for the RPALA•ATP, RPALA•CTP, RPALA•UTP•Mg
2+•UTP, RPALA•ATP•Mg
2+•ATP, and 
RPALA•CTP•Mg
2+•UTP complexes have been deposited in the Protein Data Bank under 
accession codes 4KGV, 4KGX, 4KGZ, 4KH0, 4KH1, respectively. 
 
Calculation of Small-Angle X-ray Scattering Profiles  
       X-ray scattering patterns were calculated from the experimental X-ray crystal data 
using the fast SAXS profile computation with Debye formula (FOXS) server 
(http://modbase.compbio.ucsf.edu/foxs). The FoXS server explicitly computes all inter-
atomic distances as well as models the first solvation layer based upon the atomic solvent 
accessible areas.17 Hydrogen atoms were considered implicitly. For consistency, the first 
9 residues of each regulatory chain were not included in the calculations.  
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Results and Discussion 
Influence of Mg2+ on the Allosteric Response of ATCase  
       Although it has been known for almost 50 years that divalent cations influence the 
allosteric regulation of ATCase18-20, the mechanism by which divalent cations alter the 
allosteric response has remained elusive. In fact, under a physiological concentration of 
ATP, 3.6 mM,21 Mg2+•ATP activates ATCase 2.9-fold as compared to 1.9-fold for ATP 
alone.20 Kung et al.22 have estimated that the intercellular concentrations of Mg2+ and 
Ca2+ are greater than 20 mM, and Zn2+ about 5-fold lower. Since the dissociation constant 
of M2+•NTP complexes is in the micromolar range, most of the NTPs in the cell will be 
present as M2+•NTP complexes. Therefore, it is more reasonable to consider how ATCase 
responds to the NTPs in the presence rather than the absence of M2+.  
       To ensure that the NTPs did not contain trace amounts of metal ions, all NTP 
solutions were pretreated. In order to directly compare our data to that of Wild et al.9 we 
used identical buffer, pH and Asp concentrations. Figure 5 and Table 3 shows the 
influence of Mg2+ on the activity of the enzyme in the presence of various NTPs and NTP 
combinations. Complete substrate saturation curves are shown in Figure 6.  
 
 
 
 
 
 
 Figure 5. Influence of allosteric effectors on the activity of ATCase in the absence and 
presence of Mg2+ at pH 7. Relative activity was determined in the absence or presence of 
2 mM Mg2+. Measurements with single nucleotides were performed at 2 mM, while 
measurements with pairs were performed at 1 mM each.  Assay conditions used were 
identical to those used by Wild e
metals before use. Data used for this figure are provided in Table 3.
 
 
t al.9 except that the NTPs were treated to remove trace 
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Table 3. Influence of Allosteric Effectors on the Relative Activity of ATCase in the 
Absence and Presence of Divalent Cations.a 
Relative Activity 
                                   _____________________________________________________ 
 NTP Mg2+ (2 mM) Ca2+ (2 mM) Zn2+ (2 mM) 
 none 1.0 1.0 1.0 
 ATP 1.52 ± 0.13 1.48 ± 0.04 1.31 ± 0.06 
 CTP 0.97 ± 0.05 0.83 ± 0.03 0.75 ± 0.02 
 CTP + UTP 0.19 ± 0.07 0.12 ± 0.08 0.23 ± 0.08 
a All experiments were performed at 28° C in 20 mM Bis-Tris, 20 mM Tris, and 20 mM 
CAPS buffer, pH 7.0 at saturating carbamoyl phosphate (2 mM) and 5 mM aspartate. The 
values reported are the average of four determinations. 
b Relative activity was determined by dividing the value of specific activity of ATCase in 
the presence of nucleotide(s) by that in the absence of nucleotide(s).  
 
 
 
 
 
 
 
 
 Figure 6. Asp saturation curves in the presence of NTPs and Mg
pH 8.3 (C, D).  (A, C) Data are shown in the absence of NTPs and in the absence (circle, 
black) or presence of 2 mM Mg
UTP and 2 mM Mg2+ (square, black), in the presence of 2 mM ATP, 2 mM GTP and 2 
mM Mg2+ (triangle, black) and in the presence of 4 mM ATP and 2 mM Mg
gray). (B, D) Asp saturation curves in the 
and CTP (square) in the absence of Mg
1•mg-1, at 28º C was determined colorimetrically at a saturating concentration of 
carbamoyl phosphate (2 mM) and 2 mM MgC
mM CAPS buffer at pH 7.0 and 50 mM Tris at pH 8.3.
 
 
2+ at pH 7.0 (A, B) and 
2+ (circle, gray), in the presence of 2 mM CTP, 2 mM 
absence (circle) and presence of ATP (triangle) 
2+. Specific activity, mM carbamoyl aspartate•min
l2 in 20 mM Bis-Tris, 20 mM Tris, and 20 
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CTP can inhibit ATCase in the absence of Mg2+, however, CTP has little influence on 
activity in the presence of 2 mM Mg2+ suggesting a reduced role of CTP in the allosteric 
regulation of ATCase in vivo. However, in the presence of Mg2+, the combination of the 
two end products of the pyrimidine pathway, CTP and UTP, inhibit the enzyme almost 
completely. It is known that CTP competitively inhibits its own production by binding to 
CTP synthetase, which would elevate the levels of UTP.9 The combination of CTP, UTP 
and Mg2+ as the natural allosteric inhibitor of ATCase would thus help to maintain an 
overall balance in relative pyrimidine and purine nucleotide pools without disrupting the 
balance between the CTP and UTP pools.  
       ATP is able to activate the enzyme in the absence of Mg2+, however in the presence 
of Mg2+, ATP activates the enzyme to a greater extent (Figure 5). Furthermore, using 
small-angle X-ray scattering in solution, Fetler et al.20 have reported that the R-state 
enzyme undergoes a significantly larger structural change with ATP in the presence of 
Mg2+ than in its absence. ATP and GTP activates the enzyme slightly more than ATP 
alone (see Figure 5). However, at higher concentrations of Asp, the addition of GTP to 
ATP and Mg2+substantially increases the activity (see Figure 6). Buckstein et al.21 have 
determined concentrations of ATP, GTP, UTP and CTP in mid-log phase E. coli to be 
3.56, 1.66, 0.67 and 0.33 mM respectively. These intracellular concentrations suggest that 
both end products of purine nucleotide biosynthesis, ATP and GTP, are involved in the 
allosteric regulation of ATCase.  
       These results are most relevant due to the high intercellular Mg2+ concentration, 
however other divalent cations such as Ca2+ and Zn2+ were also found to cause very 
similar nucleotide responses as Mg2+ (see Table 3). 
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Structures of ATCase with NTPs in the Presence and Absence of Mg2+ 
       Five structures of ATCase were determined in the presence of N-phosphonacetyl-L-
aspartate (PALA) to induce the R state. The ATP (RPALA•ATP) and CTP (RPALA•CTP) 
were determined in the absence of divalent cations as controls. The remaining three 
structures are NTP and Mg2+ combinations including: ATP•Mg2+, CTP•UTP•Mg2+ and 
UTP•Mg2+ of which activate, inhibit the enzyme to the greatest extent and has little 
influence on activity, respectively. A summary of the data collection and refinement 
statistics are provided in Table 1.  
       The addition of any NTP and independent of the presence of Mg2+ induces almost no 
structural alterations to the catalytic chains. As shown in Table S3, the average RMSD 
between the catalytic chains of the RPALA structure and the catalytic chains of each of the 
NTP structures determined was only 0.69 ± 0.05 Å. In contrast the average RMSD 
between the regulatory chains of the RPALA structure and the regulatory chains of each of 
the NTP structures determined was 1.41 ± 0.16 Å. Thus, the binding of the nucleotides 
has a significantly larger structural influence on the regulatory than the catalytic chains. 
The addition of any NTP with or without Mg2+ induces larger alterations in the r6 chains 
(RMSD 1.04 ± 0.28 Å) than the r1 chains (0.77 ± 0.07 Å) reinforcing the previously 
observed asymmetry in the regulatory dimer.23 
       During the T to R allosteric transition the enzyme expands by approximately 11 Å 
along the three-fold axis, as well as rotates around the 2 and 3-fold axes. The vertical 
separation24 of ATCase is a measure of the distance between the centers of mass of the 
upper and lower catalytic trimers. The vertical separation of the T state structure (PDB 
code 1ZA1) is 47.3 Å compared to 57.9 Å for the R-state structure (RPALA, PDB code 
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1D09). The corresponding vertical separations for the RPALA•ATP, RPALA•CTP, 
RPALA•UTP•Mg
2+•UTP, RPALA•ATP•Mg
2+•ATP, RPALA•CTP•Mg
2+•UTP are 57.5, 57.2, 
57.4, 57.4 and 57.3 Å respectively. Thus, the quaternary structure of all the structures 
determined here have the characteristic vertical separation of the R state of ATCase. 
None of the NTPs in the absence or presence of Mg2+ cause an appreciable alteration in 
the quaternary structure of the enzyme. 
       The binding of the various NTP•Mg2+ combinations did not induce any significant 
alterations to the positions of side chains in the active site, although this may be due to 
the high affinity of PALA orienting the active site residues. Since the NTP•Mg2+ 
combinations do not significantly alter the activity of the enzyme at saturating 
concentrations of the substrates (see Figure 6), either the presence of PALA in the active 
site makes any conformational changes or the NTPs alter the enzyme activity by binding 
to the allosteric site and preferentially stabilize the T or R states. 
       All the structures reported in the presence of Mg2+, RPALA•ATP•Mg
2+•ATP, 
RPALA•CTP•Mg
2+•UTP and RPALA•UTP•Mg
2+•UTP show electron density in the allosteric 
site corresponding to nucleotides bound in both the A and B subsites with a Mg2+ in 
between.  As an example, shown in Figure 7 is the r6 allosteric site of the 
RPALA•ATP•Mg
2+•ATP structure, additional details can be seen in Figure S1. The Mg2+ is 
octahedrally coordinated to six oxygen atoms; two from water molecules, and one from 
the β-phosphate and the γ-phosphate of each of the two NTPs in the A and B subsites. 
The water molecules coordinated to the Mg2+ have additional stabilizing interactions with 
β and γ phosphate oxygens (see Figure 7B). Thus, the allosteric site of ATCase has two 
subsites capable of binding NTPs.   
  
 
Figure 7. Allosteric site of ATCase with ATP and Mg
the r6 regulatory site with the r1 chain in blue (with transparency) and the r6 chain in 
yellow. Shown in dark blue is the electron density map at 2.5 
atoms of the two ATPs, Mg
interactions between the two ATPs and Mg
are from the r1 chain. 
 
 
 
 
 
 
        
2+. (A) Surface representation of 
σ calculated by om
2+ and waters. (B) Same view as in (A) showing the 
2+ with the enzyme. Residues with asterisks 
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Fig. S1. The allosteric site with ATP and ATP•Mg2+ bound with electron density.  
Stereoviews of r6 regulatory site of ATCase with ATP bound in (A) the absence, and (B) 
the presence of Mg2+. Shown is the electron density (blue) at 1.0 σ with the final 
coordinates of the atoms overlaid. Shown in green is the electron density map at 4.0 σ 
calculated by omitting the atoms of the ATP, or ATP and Mg2+, from the calculations. 
Hydrogen bonding interactions are shown as dash lines (magenta). 
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       As seen in Figure 8A and 8B, only one subsite is filled in the absence of a divalent 
cation. ATP and CTP bind competitively to the A subsite while UTP binds only to the B 
subsite as previously reported.25 Previous studies have shown that the concentration of 
CTP necessary to half inhibit the enzyme is approximately 6-fold lower than the 
concentration of ATP needed to activate the enzyme.26 The higher affinity of the enzyme 
for CTP compensates for the approximately 10-fold higher concentration of ATP in 
cells21 allowing the two nucleotides to compete more equally. 
       Examination of the RPALA•ATP•Mg
2+•ATP reveals that the interactions between the 
enzyme and ATP in the A subsite are very similar to those between the enzyme and ATP 
in the RPALA•ATP structure determined in the absence of Mg
2+ (compare Figures 8A and 
8D). The phosphates of ATP bound in the B subsite interact with the backbone nitrogen 
of Glu52 as well as the side chains His20, Ser50 and Lys56, all of which are involved in 
the binding of UTP in the B subsite (compare Figures 8D and 8F). The ε-amino of Lys60 
exhibits a water-mediated interaction and a polar interaction with the N7 and 6-amino 
group of the adenine ring, respectively (Figure 8D). However, in the B subsite of the 
adjacent regulatory chain there is a direct interaction between Lys60 and N7.  
       The allosteric site of the RPALA•CTP•Mg
2+•UTP structure is shown in Figure 8E. 
CTP was modeled into the A subsite and UTP was modeled into the B subsite based upon 
the subsite specificity previously determined.4 The 4-amino group of the cytosine in the 
A subsite acts as a hydrogen bond donor to the backbone carbonyls of Ile12 and Tyr89. 
Furthermore, all the interactions to CTP observed in the RPALA•CTP structure in the 
absence of Mg2+ are also observed in the RPALA•CTP•Mg
2+•UTP structure (compare 
Figures 8B and 8E).         
 Figure 8.  (Top) Structural comparison of ATP, CTP and UTP bound in the A subsite. 
ATP (A), CTP (B) and UTP (C) are shown in A
ATCase. In the case of UTP (C), the A subsite is only occupied in the presence of Mg
(not shown). Hydrogen-bonding interactions are shown as dash lines (black).  (Bottom) 
Structural comparison of the allosteric sit
of ATCase with (D) ATP•Mg
bound in the A and B subsites. For clarity, Asp19 is shown but not labeled. The Mg
shown as a gray sphere and coordinated ligand inte
Hydrogen-bonding interactions are shown as dash lines (black). Water ligands to Mg
are shown as red spheres. For clarity the first 10 residues of each regulatory chain are not 
shown. This figure was generated using 
 subsite of the r6 regulatory domain of 
e with Mg2+ and NTPs. The r6 regulatory chain 
2+•ATP, (E) CTP•Mg2+•UTP, and (F) UTP•Mg
ractions are shown with magenta lines. 
CHIMERA.27 
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       The allosteric site of the RPALA•UTP•Mg
2+•UTP structure is shown in Figure 8F with 
UTP bound in both the A and B subsites. The interactions of UTP in the A subsite are 
different from those observed for CTP in the A subsite (compare Figures 8E and 8F). In 
the RPALA•UTP•Mg
2+•UTP structure the phosphates portion of UTP in the A subsite make 
the same interactions with His20 and Lys94 as ATP and CTP do. However, comparing 
the interactions between the pyrimidine rings of CTP and UTP, UTP has only half the 
number of interactions that CTP has in the A subsite. There is a polar interaction between 
Lys60 and the 2-keto oxygen of both CTP and UTP, but the 4-keto group of UTP is 
unable to hydrogen bond with the backbone carbonyls of Tyr89 and Ile12. Since the 
pyrimidine ring of UTP is not held as strongly, it is somewhat displaced relative to CTP, 
which may explain the inability of UTP•Mg2+ to inhibit the enzyme. This displacement 
prevents an interaction between the uridine N3 and the backbone of Ile12. The uridine of 
the UTP in the B subsite is held by two interactions, each to the ε-amino group of Lys60 
(see Figure 8F). The majority of the binding affinity comes from interactions of the 
triphosphate with the Mg2+ and the side chains of His20, Ser50, Lys56 and the backbone 
of Glu52. The side chain of Asp19 also has a water-mediated interaction that further adds 
to the triphosphate interactions (see Figure 8F).  
       Figure 9 compares the structural consequences of NTPs and Mg2+ binding to the 
allosteric site of the regulatory chain of ATCase. In this figure the RPALA structure 
without nucleotide effectors is compared with the RPALA•ATP•Mg
2+•ATP and the 
RPALA•CTP•Mg
2+•UTP structures.  ATP•Mg2+ substantially activates the enzyme while 
CTP•Mg2+•UTP causes the most inhibition. The position of the N-terminal region of the 
regulatory chain is altered in the RPALA•ATP•Mg
2+•ATP structure as compared to the  
  
Figure 9. Structure changes induced by the binding of ATP + Mg
RPALA•ATP•Mg
2+•ATP) or CTP + UTP + Mg
unliganded r6 regulatory chain of ATCase in the R
The two structures with ligands were aligned to the structure in the absence of regulatory 
nucleotides. For clarity the two ATPs and Mg
RPALA•ATP•Mg
2+•ATP are not shown, however they occupy positions very similar to 
CTP and UTP.  The side chains of the r6 c
the adjacent catalytic chain (c6) are shown with transparency on the right.
 
2+ (red, RPALA•CTP•Mg
2+•UTP
-state (gray, RPALA, PDB ID 1D09).  
2+ that are bound in the 
hain which interact via hydrogen bonding with 
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other two. As seen in Figure 10, the molecular basis for the alternation in position of the 
N-terminal region is due to the larger size of the purine ring of ATP as compared to the 
pyrimidine ring of UTP in the B subsite. In the RPALA•CTP•Mg
2+•UTP structure the 
carbonyl oxygen at the 2 position and the nitrogen at the 3 position of the pyrimidine ring 
interact with the backbone of Val9. However, in the RPALA•ATP•Mg
2+•ATP structure the 
purine ring of the ATP in the B subsite fits into the site by displacing the N-terminal, the 
escalated consequence of which might induce the interchain interaction of the N-termini. 
       Both structures with NTPs and Mg2+ have a significant shift in the 50’s loop region, 
as residues from this loop (Ser50, Glu52, Lys56) interact with the NTP in the B subsite. 
Strand S5’, part of the five stranded sheet in the Al domain that bridges to the Zn domain, 
is shifted in both structures with NTPs and Mg2+ as compared to the R•PALA structure.  
In the interface between the Al-Zn domains (strand S5’ and helix H2’) the shifts in the 
R•PALA•ATP•Mg2+•ATP and the R•PALA•CTP•Mg2+•UTP structures are in opposite 
directions. This alteration in the Al-Zn interface alters hydrophobic contacts that 
previously have been shown to be important for the allosteric regulation.28, 29 In the case 
of ATP+Mg2+ bound structure, helix H1 and helix H2 show less separation from each 
other compared to that of no ligand or CTP+UTP+Mg2+ bound structures. The signal of 
ATP+Mg2+ binding might exert long-range effect to perturb the orientation of two 
helixes, causing the hydrophobic area in between contracted. Notable is the lack of 
significant structural motions in the region around the structural Zn ion in the Zn domain, 
the region of the Zn domain that interacts with the adjacent catalytic chain, indicating that 
the binding of nucleotides effectors doesn’t pass from regulatory chain to catalytic chain 
through alteration in structure of interface of zinc domain and CP domain. The C-
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terminal helix (Helix H3’) undergoes a dramatic reorientation resulting in alterations to 
the position of the C-terminus of the regulatory chain. Helix H3 includes His147r, 
Asn148r and Val149r. In CTP+UTP+Mg2+ structure, the carbonyl group on the 
carboxamide side chain of Asn148r forms a salt link with the nitrogen atom on the 
imidazole ring of His147r. In ATP+Mg2+ structure, helix H3 pivoted towards the 
hydrophobic pocket, which might due to the hydrophobic pocket contraction resulted 
from ATP+Mg2+ binding. Alongside the carboxamide side chain of Asn148r shifted and 
formed salt link with His147r by its amino group instead of the carbonyl group. The 
interactions between the C-terminus of the r1 chain and the c4 catalytic chain in the T 
state have been shown to be involved in allosteric regulation. For example, Xi et al.30 
have previously shown that the removal of two residues from the C-terminus of the 
regulatory chain is sufficient to abolish the ability of CTP to inhibit the enzyme. 
 
 
  
Figure 10. Stereoview comparison of the r6 regulatory site of ATCase from the 
RPALA•ATP•Mg
2+•ATP (green carbons
structures. Hydrogen bonding interactions are shown with dotted lines. The arrow 
indicates the motion of the segment of the N
 
 
 
 
 
) and the RPALA•CTP•Mg
2+•UTP (yellow carbons
-terminal shown. 
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Comparison of the Solution and Crystal structures of ATCase•PALA Complex in 
the Presence of ATP and Mg2+•ATP 
       Structural information on the R-state of ATCase in the presence of ATP and 
ATP•Mg2+ has been obtained using small-angle X-ray scattering in solution (SAXS). 
Fetler and Vachette20 showed that the solution structure of ATCase•PALA (RSOL) was 
altered in the presence of ATP, and in the presence of ATP•Mg2+ to a larger extent. The 
SAXS data was then used to model the structures of the ATCase•PALA complex in the 
presence of ATP (RSOL•ATP) and ATP•Mg
2+ (RSOL•ATP•Mg
2+). The RSOL•ATP and the 
RSOL•ATP•Mg
2+ modeled structures were elongated along the 3-fold axis 2.8 Å and 4.4 Å 
more than the RPALA crystal structure. Furthermore, the catalytic subunits of the 
RSOL•ATP and the RSOL• ATP•Mg
2+ structures rotated 8° and 13° more around the 3-fold 
axis and the regulatory subunits rotated 9° and 15° more around their respective 2-fold 
axes, respectively, than the RPALA crystal structure. 
       The structural changes proposed by Fetler and Vachette20 are not observed when 
comparing the RPALA crystal structure obtained in the absence of nucleotides
13 with the 
RPALA•ATP and the RPALA•ATP•Mg
2+•ATP crystal structures reported here. For both the 
RPALA•ATP and RPALA•ATP•Mg
2+•ATP structures, neither the expansion along the 3-fold 
axis nor the rotations of the subunits around the 3-fold and 2-fold axes differ significantly 
from that observed for the RPALA structure without allosteric effectors. The structural 
models determined based on the SAXS data20 are inconsistent with the crystal structures 
suggesting that the structure of the enzyme in solution is different from that in crystal. 
       In order to investigate the discrepancy between the solution and crystal structures, we 
calculated SAXS profiles based on the atomic positions as determined by X-ray 
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crystallography. As seen in Figure 11, the calculated SAXS profile for RPALA without 
regulatory effectors is different from that calculated for the RPALA•ATP•Mg
2+•ATP 
structure. The largest difference in the SAXS patterns is in the region of the first 
subsidiary minimum and maximum, exactly as was observed experimentally20However, 
if all the atoms constituting ATP and Mg2+ are removed from the RPALA•ATP•Mg
2+•ATP 
coordinates and the SAXS pattern is recalculated, the pattern obtained is essentially 
identical to the pattern calculated for the RPALA structure in the absence of allosteric 
effectors. These calculations indicate that the RSOL•ATP and RSOL•ATP•Mg
2+ structures 
of ATCase reported by Fetler and Vachette20 are incorrect, and that the observed 
difference in scattering between the R-state enzyme in the absence and presence of ATP 
and ATP•Mg2+ is due exclusively to the extra scattering caused by the bound ligands.  
These results also indicate that the solution and crystal structures of ATCase are virtually 
identical. 
 
 
 
 Figure 11. Calculated SAX
biological unit of ATCase were calculated using the FOXS Server 
PDB ID 1ZA1 with CTP removed) and R
shown are the calculated SAXS profiles for the R
ligands (red) and the same structure with the ATP and Mg
dashed).
S scattering curves of ATCase. SAXS profiles of the 
17 in the T
-state with PALA (blue, PDB ID 1D09). Also 
PALA•ATP•Mg
2+•ATP structure with 
2+ atoms removed (black 
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Nucleotide Site Specificity 
       The ATCase structures reported here confirm that the allosteric site on each 
regulatory chain of ATCase is actually a dinucleotide site composed of two subsites that 
can bind nucleotide triphosphates. Furthermore, the nucleotide that occupies each of the 
two independent sites must be considered in any model of allosteric regulation of 
ATCase. The A subsite can bind CTP, ATP, and UTP, while the B subsite can bind ATP 
and UTP. Although GTP has been shown to bind to the allosteric site31, its site 
specificity, or lack thereof, has not been established. The simultaneous binding of two 
nucleotides to the A and B subsites, in any combination, is dependent upon the presence 
of a divalent cation. In the absence of divalent cations, ATP and CTP bind with high 
affinity only to the A subsite (see Figure 8A and 8B). The only NTP that is able to bind to 
the B subsite with reasonable affinity in the absence of divalent cations is UTP.25   
       The preferential binding of CTP to the A subsite and UTP to the B subsite is due to 
the interactions involving the functional group difference at the 4 position of the 
pyrimidine ring. The 4-keto group of uracil cannot interact with the A subsite because 
there are no appropriately positioned hydrogen-bond donors (see Figure 8F). However, 
the backbone carbonyls of Ile12 and Tyr89 serve as hydrogen-bond acceptors for the 4-
amino group of the cytosine ring of CTP (see Figure 8E). The 6-amino group of adenine 
interacts with the same two groups on the enzyme to provide the specificity with respect 
to ATP (see Figure 8D). 
       In the presence of Mg2+, ATP can occupy both the A and B subsites. When the two 
subsites are populated in this fashion the enzyme is more activated than when ATP is 
bound just to the A subsite (see Figure 5). The combination of CTP binding at the A 
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subsite and UTP binding to the B subsite results in the highest level of inhibition of the 
enzyme. In fact, in the presence of Mg2+, neither CTP nor UTP alone inhibits the enzyme 
significantly (see Figure 5). Cockrell and Kantrowitz4 have described the selective 
binding of the nucleotides CTP and UTP to the A and B subsites, respectively. Part of the 
subsite selectivity is due to electrostatic interactions between the pyrimidine ring and 
Lys60, a residue that lies at the interface between the A and B subsites and has 
interactions with the nucleotides bound in each subsite. Therefore, an unfavorable 
electrostatic interaction between Lys60 and the 4-amino group of CTP precludes the 
binding of CTP to the B subsite. It is likely that the CTP•Mg2+ complex has a lower 
binding affinity to the allosteric site than CTP, and explains why 2 mM CTP•Mg2+ does 
not inhibit the enzyme. The structural basis for the ability of ATP to bind to both the A 
and B subsites can also be ascribed to electrostatic interactions between ATP and Lys60. 
The adenine N3 of ATP in the A subsite interacts with Lys60, and in the B subsite Lys60 
interacts with N7 and the 6-amino group, all of which bear a partial negative charge.32 
 
The Role of the N-termini of the Regulatory Chains of ATCase in Allosteric 
Regulation 
       In most structures of wild-type and mutant versions of ATCase, the N-termini of the 
regulatory chains are disordered to a significant extent to make the determination of the 
atomic positions of the residues impossible. Depending upon the structure, between 1 and 
10 residues have been excluded. Part of the reason for the disordered N-termini is that 
this part of the protein makes interactions with the nucleotide in the B subsite, structures 
of which have not been available. The RPALA•CTP•Mg
2+•UTP and 
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RPALA•ATP•Mg
2+•ATP structures, reported here, correspond to highly inhibited and 
activated forms of the enzyme, respectively. As discussed above, in these two structures 
the N-terminal region of the regulatory chains exhibit completely different 
conformations.  
       Shown in Figure 12A are the allosteric domains of the regulatory subunit of the 
RPALA•CTP•Mg
2+•UTP structure. The N-termini of the r1 and r6 chains are parallel to one 
another at the dimer interface. Shown in Figure 12B are the allosteric domains of the 
regulatory subunit of the RPALA•ATP•Mg
2+•ATP structure. The larger purine ring of ATP 
in the A subsite displaces the N-terminus of the r1 chain into the allosteric site of the r6 
chain and interacts with the ATP bound in the B subsite of the r6 chain and vice versa. 
The penetration of the N-terminal region into the opposing regulatory chain positions 
Lys6 to help neutralize the negative charges on the two triphosphates. Additional 
stabilization of the nucleotide in the B subsite is provided by hydrophobic interactions 
with Leu7 and Val9. The crossover of the N-terminal region into the opposite regulatory 
chain of the dimer is particularly intriguing, as this would enhance the strength of the 
interface between the regulatory chains within the regulatory dimer, providing a new 
mode by which ATP can stabilize the R state of ATCase. The position of the N-termini in 
the RPALA•CTP•Mg
2+•UTP structure would provide no added stabilization to this 
interface thus neutralizing the effect of ATP and by inference, destabilizing the R state.  
 
 Figure 12. Alternate conformations of the N
CTP•Mg2+•UTP (A) and RPALA
domains of the regulatory subunit. In (A) the N
B subsite within their own chain, while in (B) the N
penetrates into B subsite of the other regulatory chain. In the R
RPALA• ATP•Mg
2+•ATP structures, 6 and 3 residues were omitted from the N
to weak electron density. Figure S2 shows the relationship of the portion of the regulatory 
subunit shown in this figure to the holoenzyme.
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Figure S2. The regulatory subunit of ATCase in the context of the holoenzyme. The 
structure of the RPALA•ATP•Mg
2+•ATP holoenzyme composed of two catalytic trimers 
and three regulatory dimers is shown on the left. The catalytic trimers (light brown) 
comprise the upper and lower parts of the macromolecule. Surrounding the catalytic 
trimers are the three regulatory dimers, with the two chains shown in green and yellow. 
The front most regulatory dimer is shown enlarged on the right. The two ATP molecules 
and the Mg2+ in each regulatory chain are visible. The N-terminal of each regulatory 
chain penetrates into the allosteric site of the adjacent chain thereby strengthening the 
interface between the two chains of the regulatory dimer. 
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Allosteric Regulation is Governed by Both Subsites in Each Regulatory Chain of 
ATCase 
       Previous kinetic studies of single amino acid substitutions have been performed on 
residues identified here as involved in nucleotide binding to the A and B subsites. In the 
A subsite, Lys9433 is critical for nucleotide binding. Residues that interact with the 
nucleotide in both subsites include Asp19, His20 and Lys60. The K60A mutation 
eliminates CTP inhibition and reduces the affinity of ATP. The mutant enzymes D19A34, 
H20A35, and K56A36 lose their ability to be inhibited synergistically by UTP in the 
presence of CTP. The loss of synergistic inhibition could not previously be explained 
from a structural perspective, especially for the K56A mutation as the B subsite had not 
been discovered. As seen in Figure 8D, Asp19, His20 and Lys56 all provide stabilizing 
interactions to the ATP bound in the B subsite and have few or no interactions with CTP 
bound in the A subsite. Mutations at residues Asp4, Lys6, and Leu7 of the N-terminal 
region of the regulatory chain all influence the regulatory properties of the enzyme.37 As 
seen in Figure 12, Leu7 is involved in a hydrophobic interaction with either the purine or 
pyrimidine ring of bound nucleotides and Lys6 helps to neutralize the charge of the two 
triphosphates in the RPALA•ATP•Mg
2+•ATP structure (Figure 8D). These site-specific 
amino acid substitutions provide functional evidence that both the A and B subsites play 
a role in the allosteric regulation of ATCase.  
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A New Model of Allosteric Regulation of ATCase Involving a Dinucleotide Binding 
Site 
       Based upon the kinetics and the five X-ray structures reported here, along with the 
previously reported RPALA•UTP 
25, T•dCTP•Mg2+•UTP and T•CTP•Mg2+•UTP 
structures4, a new model of allosteric regulation of ATCase can be proposed. 
       1) Each regulatory chain of ATCase can bind two nucleotides simultaneously, but 
only in the presence of a divalent cation such as Mg2+ (see Figure 8D, 8E, and 8F). 
       2) Reports from the last 57 years stating that CTP is the allosteric feedback inhibitor 
of ATCase are inaccurate. Although CTP in the absence of divalent cations can inhibit 
the enzyme, in the presence of M2+ ions at or below physiological concentrations, CTP 
does not significantly inhibit the enzyme. Reports from the last 24 years that ATCase is 
synergistically inhibited by UTP in the presence of CTP are incorrect. In the absence of 
metals, the combination of CTP and UTP does not inhibit the enzyme more than CTP 
alone (see Figure 5). In the presence of a Mg2+, Ca2+ or Zn2+ at concentrations less than 
intracellular (2 mM), CTP does not significantly inhibit ATCase (see Figure 5 and Tables 
S1 and S2). In the presence of Mg2+, Ca2+ or Zn2+ at concentrations below physiological, 
the allosteric inhibitor of ATCase is the combination CTP•M2+•UTP with CTP binding to 
the A subsite and UTP binding to the B subsite. Thus, both end products of the 
pyrimidine pathway, CTP and UTP, act together to feedback inhibit ATCase.  
       3) Although ATCase can be activated by the binding of ATP in the absence of 
divalent cations, the enzyme can be activated to a larger extent by ATP•M2+. Although 
GTP was never thought to play a significant role in allosteric regulation of ATCase, it can 
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function in conjunction with ATP•Mg2+ (see Figure 5 and 6). Thus, both end products of 
the purine pathway, ATP and GTP can act together to allosterically activate ATCase. 
       4) The conformation of the N-termini of the regulatory chains is governed by the 
nucleotides bound in the A and B subsites. The inhibited form of the enzyme with 
CTP•Mg2+•UTP bound exhibits an intrachain orientation of the N-termini, while the 
activated form of the enzyme with ATP•Mg2+•ATP bound exhibits an interchain 
orientation of the N-termini. Thus, the activated form of the enzyme has increased 
stabilization of the interface between the two chains of the regulatory dimer, suggesting 
that these interfaces are functionally important for the stabilization of the T and R states 
of ATCase. This selective stabilization of the T and R states provides an explanation for 
how the nucleotides function in the activation and inhibition of ATCase that is consistent 
with the model of allostery proposed by Monod, Wyman and Changeux 38. 
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